Non-Active Secondary Progressive Multiple Sclerosis
3 clinical trials · Condition
◉ Watch Non-Active Secondary Progressive Multiple Sclerosis
| Record | Firm | Date |
|---|---|---|
| Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients (NCT06802328) | Tiziana Life Sciences LTD |
Track Non-Active Secondary Progressive Multiple Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.